SectorLife Science Tools and Services
Established Date25/08/1999
Listing Date13/11/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees92
Fiscal Year Ends31/12
Security TypeCommon stock
Office address203 Redwood Shores Parkway, Suite 500, Redwood City, California 94065
Business
IntroductionSoleno Therapeutics, Inc., was incorporated in Delaware on August 25, 1999. The company focuses on the development and commercialization of novel therapies for the treatment of rare diseases. The company's lead drug candidate, DCCR (diazachol) sustained-release tablets, is a potent ATP-sensitive potassium (KATP) channel activator.
